Detalhe da pesquisa
1.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Lancet
; 401(10374): 347-356, 2023 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739136
2.
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.
Pharmacogenet Genomics
; 30(6): 131-144, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317559
3.
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.
Eur J Hum Genet
; 28(4): 508-517, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745289
4.
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
Clin Pharmacol Ther
; 106(4): 866-873, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038729
5.
One non-believer: Response to "Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-emptive Pharmacogenetic Testing".
Basic Clin Pharmacol Toxicol
; 126(1): 7-8, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670867